Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2012-001128-36-ES
EUCTR2012-001128-36-ES
Active, Not Recruiting
N/A

Integral care program with or without palliative chemotherapy in patients with advanced cancer: multicentre randomized clinical trial. - PAI (Programa de atención Integral)

Institut de Recerca HSCSP0 sitesJune 25, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPatients with advanced cancer.Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
DrugsCisplatino FERRER FARMAFluorouracilo Ferrer FarmaGemcitabina STADADoxorubicina SandozETOPÓSIDO FERRER FARMATemozolomida SandozOxaliplatino ratiopharmDacarbazina RCA

Overview

Phase
N/A
Intervention
Not specified
Conditions
Patients with advanced cancer.
Sponsor
Institut de Recerca HSCSP
Status
Active, Not Recruiting
Last Updated
12 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 25, 2012
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Institut de Recerca HSCSP

Eligibility Criteria

Inclusion Criteria

  • •1\. Men and women ? 18 years of age.
  • •2\. Patients potentially eligible to receive a new chemotherapy treatment and whose clinical condition, according to the oncologist responsible, does not identify any therapeutic strategy clearly superior to another, in the light of available scientific evidence.
  • •3\. Patients with advanced cancers that have been treated with chemotherapy but have not submitted a complete response to treatment or who, having presented, are now in a situation of recurrence or disease progression
  • •5\. Patients who have previously completed a number of chemotherapies. Depending on the type of cancer will be considered:
  • •? Cancers of the digestive and gastrointestinal
  • •? Head and Neck Cancers
  • •? Cancer Bronchopulmonary
  • •? Urological Cancer
  • •? Gynecologic Cancer
  • •? Central Nervous System Cancer

Exclusion Criteria

  • •1\. Patients who are in course of any chemotherapy. Not be considered an exclusion criterion that the patient is enrolled in any other concomitant therapy (e.g., hormone or radiation therapy).
  • •2\. Patients with contraindications to chemotherapy.
  • •3\. Patients who refuse to enter into the clinical trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
N/A
COPD Palliative and Supportive care Implementatio
NL-OMON26565ung Alliance Netherlands, Leiden University Medical Center, Radboud University Medical Center347
Recruiting
N/A
Implementation of an integrated care programme to avoid fragility fractures in older adults in 18 Bavarian hospitals - study protocol for the cluster-randomised controlled fracture liaison service FLS-CAREM81.9S72.0Osteoporosis, unspecifiedFracture of neck of femur
DRKS00022237Klinik für Allgemeine- Unfall und Wiederherstellungschirurgie1,216
Completed
N/A
Integrating specialist palliative care into residential care for older people: a stepped wedge trial (INSPIRED trial)Dyingageingdementia
ACTRN12617000080325Australian Catholic University720
Active, Not Recruiting
N/A
Is it possible to introduce a palliative care approach to primary care clinics to improve the quality of life of patients with chronic lung disease in South Africa?
ISRCTN44976471ational Institute for Health Research105
Not Yet Recruiting
Phase 2
A clinical trial to study the effect of starting early palliative care with chemotherapy at diagnosis of advanced sarcoma compared to chemotherapy alone.
CTRI/2019/05/019367VIKAS GARG